Janet Dancey

55.5k citations
205 papers · 38.9k · 6 hit papers · h-index 69

Impact in

  • Oncology top 0.02%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
  • Hepatology top 0.2%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Colorectal Cancer Treatments and Studies 17
    • Lung Cancer Research Studies 13
    • HER2/EGFR in Cancer Research 11
    • PI3K/AKT/mTOR signaling in cancer 22
    • Cancer therapeutics and mechanisms 17

Janet Dancey

199 papers receiving 38.4k citations

Janet Dancey's Hit Papers

iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics 2017 · 1.6k citations
1.6k0+8+17Years since publication5.0k10.0k15.0k20.0k

Peers

Janet Dancey
Comparison fields: 5 of 155
  • Oncology 12.9k
  • Hepatology 2.5k
  • Pulmonary and Respiratory Medicine 10.1k
  • Cancer Research 4.1k
  • Otorhinolaryngology 1.1k
Replace Richard Kaplan with:
Richard Kaplan United Kingdom
Larry Rubinstein United States
Susan G. Arbuck United States
Jan Bogaerts Belgium
John D. Hainsworth United States
Lalitha Shankar United States
Denis Lacombe Belgium
M. van Glabbeke Belgium
Daniel J. Sargent United States
Ming‐Sound Tsao Canada
Janet Dancey relative to Richard Kaplan United Kingdom Richard Kaplan's profile →
Citations per field
00.5×1.5×
Richard Kaplan · 1×
Citations per year

Countries citing papers authored by Janet Dancey

Since Specialization
Citations

This map shows the geographic impact of Janet Dancey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Dancey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Dancey more than expected).

Fields of papers citing papers by Janet Dancey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Dancey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Dancey. The network helps show where Janet Dancey may publish in the future.

Co-authors

The 25 scholars most cited alongside Janet Dancey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Janet Dancey Line = papers co-authored together Janet Dancey links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 205 papers — load more, or switch the sort, to bring in the rest.

#Work
1
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Hit paper breakdown →
200821190
2
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Hit paper breakdown →
20001727
3
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Hit paper breakdown →
20171580
4
RECIST 1.1—Update and clarification: From the RECIST committee
Hit paper breakdown →
20161258
5
Phase II Trial of Gefitinib in Recurrent Glioblastoma
Hit paper breakdown →
2003560
6
Phase II Trial of Temsirolimus (CCI-779) in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study
Hit paper breakdown →
2005551
7 2003407
8 2010324
9 2013318
10 2005309
11 2003301
12 2006285
13 2006260
14 2011256
15 2007236
16 2016229
17 2012225
18
Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
2000224
19 2009224
20 2009222

About Janet Dancey

Janet Dancey is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 205 papers that have together received 38.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), PI3K/AKT/mTOR signaling in cancer (22 papers), Cancer Genomics and Diagnostics (22 papers), Colorectal Cancer Treatments and Studies (17 papers), Cancer therapeutics and mechanisms (17 papers), Lung Cancer Research Studies (13 papers), Glioma Diagnosis and Treatment (12 papers) and HER2/EGFR in Cancer Research (11 papers). The work is most often cited by research in Oncology (12.9k citations), Hepatology (2.5k citations), Pulmonary and Respiratory Medicine (10.1k citations), Cancer Research (4.1k citations) and Otorhinolaryngology (1.1k citations). Janet Dancey has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Lalitha Shankar, Lawrence H. Schwartz, Jan Bogaerts, Stephen J. Gwyther, Larry Rubinstein, Lori E. Dodd, Margaret Mooney, E. Eisenhauer, Daniel J. Sargent and P. Therasse. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Clinical Cancer Research, Cancer Chemotherapy and Pharmacology and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact